TNF receptor p55 and IL-872 and IL-877 isoforms: Blood and urine levels in breast cancer patients

Journal of Immunotoxicology

Volumn 6, Issue 4, 2009, Pages 235-242

  Shichkin, Valentin P ^a   Lon, Anna D ^b   Yugrinova, Ludmila G ^b   Grinevich, Yury A ^b   Belova, Oksana B ^c   Berezhnaya, Ninel M ^c   Akalovich, Svetlana ^d   Pashkova, Oksana ^d   Voitenok, Nikolai N ^e  

^a Ukraine University   (Ukraine)

^b NATIONAL CANCER INSTITUTE   (Ukraine)

^c Institute of Experimental Pathology Oncology and Radiology   (Ukraine)

^d Belarusian Research and Production Center for Hematology and Transfusiology   (Belarus)

^e Fund for Molecular Hematology and Immunology   (Russian Federation)

Author keywords

Breast cancer; Interleukin 8; Tumor necrosis factor

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 8; INTERLEUKIN 8 72; INTERLEUKIN 8 77; ISOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR P55; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE STATUS; IMMUNOLOGICAL MONITORING; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; URINALYSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-8; MIDDLE AGED; NEOPLASM STAGING; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR DECOY RECEPTORS; URINALYSIS;

EID: 70450216056     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.3109/15476910903299835     Document Type: Article

References (33)

1. Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., and Sethi, G. 2006. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 72:1605-1621.
2. Ahmed, M. I., Salahy, E. E., Fayed, S. T., El-Hefnawy, N. G., and Khalifa, A. 2001. Human papillomavirus infection among Egyptian females with cervical carcinoma: Relationship to spontaneous apoptosis and TNF?. Clin. Biochem. 34:491-498.
3. Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., and Strieter, R. M. 2000. CXC chemokines in angiogenesis. J. Leukocyte Biol. 68:1-8.
4. Casey, L. C. 2000. Immunologic response to infection and its role in septic shock. Crit. Care Clin. 16:193-213.
5. Dumont, R. A., Car, B. D., Voitenok, N. N., Junker, U., Moser, B., Zak, O., and O'Reilly, T. 2000. Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect. Immun. 68:5756-5763.
6. Engelmann, H., Holtmann, H., Brakebusch, C., Avni, Y. S., Sarov, I., Nophar, Y., Hadas, E., Leitner, O., and Wallach, D. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265:14497-14504.
7. Folkman, J. 1971. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285:1182-1186.
8. Grosen, E. A., Granger, G. A., Gatanaga, M., Ininns, E. K., Hwang, C., DiSaia, P., Berman, M., Manetta, A., Emma, D., and Gatanaga, T. 1993. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy. Gynecol. Oncol. 50:68-77.
9. Hantschel, O., Gstoettenbauer, A., Colinge, J., Kaupe, I., Bilban, M., Burkard, T. R., Valent, P., and Superti-Furga, G. 2008. The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia. Mol. Oncol. 2:272-281.
10. Ko, Y., Mukaida, N., Panyutich, A., Voitenok, N. N., Matsushima, K., Kawai, T., and Kasahara, T. 1992. A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J. Immunol. Meth. 149:227-235.
11. Kuhlmann, U. C., Chwieralski, C. E., Reinhold, D., Welte, T., and Buhling, F. 2009. Radiation-induced matrix production of lung fibroblasts is regulated by interleukin-8. Int. J. Radiat. Biol. 85:138-143.
12. Lin, P. L., Plessner, H. L., Voitenok, N. N., and Flynn, J. L. 2007. Tumor necrosis factor and tuberculosis. J. Invest. Dermatol. 12:22-25.
13. Maheshwari, A., Voitenok, N. N., Akalovich, S., Shaik, S. S., Randolph, D. A., Sims, B., Patel, R. P., Killingsworth, C. R., Fallon, M. B., and Ohls, R. K. 2009. Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine 46:12-16.
14. Mohkam, M., Karimi, A., Karimi, H., Sharifian, M., Armin, S., Dalirani, R., and Abdollah, F. 2008. Urinary interleukin-8 in acute pyelonephritis of children: A before-after study. Iran. J. Kidney Dis. 2:193-196.
15. Nashkevich, N., Akalovich, S., Louneva, N., Heavner, G., and Viotenok N. 2002. A monoclonal antibody and an enzyme immunoassay for human Ala-IL- 8(77). J. Immunol. Meth. 270:37-51.
16. Or, R., Kalinkovich, A., Nagler, A., Weisman, Z., Naparstek, E., Weiss, L., and Hahn, T. 1996. Soluble tumor necrosis factor (sTNF) receptors: A possible prognostic marker for bone marrow transplantation-related complications. Cytokines Mol. Ther. 2:243-250.
17. Pohl, A., and Lenz, H. J. 2008. Individualization of therapy for colorectal cancer based on clinical and molecular parameters. Gastrointest. Cancer Res. 2:S38-S41.
18. Ramjeesingh, R., Leung, R., and Siu, C. H. 2003. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J. 17:1292-1294.
19. Redl, H., Schlag, G., Adolf, G. R., Natmessnig, B., and Davies, J. 1995. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect. Immun. 63:297-300.
20. Scheibenbogen, C., Mohler, T., Haefele, J., Hunstein, W., and Keilholz, U. 1995. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load. Melanoma Res. 5:179-181.
21. Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., and Xie, K. 1999. Constitutive and inducible interleukin-8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 5:3711-3721.
22. Shubik, P. 1982. Vascularization of tumors: A review. J. Cancer Res. Clin. Oncol. 103:211-226.
23. Strieter, R. M., Kunkel, S. L., and Bone, R. C. 1993. Role of tumor necrosis factor-? in disease states and inflammation. Crit. Care. Med. 21:S447-S463.
24. Sylvester, I., Yoshimura, T., Sticherling, M., Schröder, J. M., Ceska, M., Peichl, P., and Leonard, E. J. 1992. Neutrophil attractant protein-1- immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J. Clin. Invest. 90:471-481.
25. Tannock, I. 1982. Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation. Cancer Res. 42:4921-4926.
26. Terui, Y., Ikeda, M., Kasahara, T., Ohtsuki, T., Uwai, M., Mori, M., Itoh, T., Tanaka, M., Yamada, M., Shimamura, S., Ishizaka, Y., Ikeda, K., Ozawa, K., Miura, Y., and Hatake, K. 1998. Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8. Blood 92:2672-2680.
27. Terui, Y., Tomizuka, H., Mishima, Y., Ikeda, M., Kasahara, T., Uwai, M., Mori, M., Itoh, T., Tanaka, M., Yamada, M., Shimamura, S., Ishizaka, Y., Ozawa, K., and Hatake, K. 1999. NH2-terminal pentapeptide of endothelial interleukin-8 is responsible for the induction of apoptosis in leukemic cells and has an anti-tumor effect in vivo. Cancer Res. 59:5651-5655.
28. Uchikawa, C., Shinozaki, T., Nakajima, T., and Takagishi, K. 2009. Cytokine synthesis by chondroblastoma: Relation to local inflammation. J. Orthop. Surg. (Hong Kong) 17:56-61.
29. Van Damme, J., Van Beeumen, J., Opdenakker, G., and Billiau, A. 1988. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167:1364-1376.
30. Wang, Y., Yang, J., Gao, Y., Du, Y., Bao, L., Niu, W., and Yao, Z. 2005. Regulatory effect of e2, IL-6, and IL-8 on the growth of epithelial ovarian cancer cells. Cell. Mol. Immunol. 2:365-372.
31. Warzocha, K., Salles, G., Bienvenu, J., Bastion, Y., Dumontet, C., Renard, N., Neidhardt-Berard, E. M., and Coiffier, B. 1997. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J. Clin. Oncol. 15:499-508.
32. Xu, L., and Fidler, I. J. 2000. Acidic pH-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res. 60:4610-4616.
33. Xu, L., Xie, K., Mukaida, N., Matsushima, K., and Fidler, I. J. 1999. Hypoxiainduced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res. 59:5822-5829.